Linden Thomas Advisory Services LLC Acquires New Holdings in USANA Health Sciences, Inc. $USNA

Linden Thomas Advisory Services LLC acquired a new stake in shares of USANA Health Sciences, Inc. (NYSE:USNA) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 8,059 shares of the company’s stock, valued at approximately $246,000.

Other institutional investors also recently bought and sold shares of the company. Teacher Retirement System of Texas purchased a new position in USANA Health Sciences in the first quarter worth $888,000. Envestnet Portfolio Solutions Inc. purchased a new position in USANA Health Sciences in the second quarter worth $274,000. US Bancorp DE grew its holdings in USANA Health Sciences by 13.1% in the first quarter. US Bancorp DE now owns 4,611 shares of the company’s stock worth $124,000 after purchasing an additional 535 shares during the last quarter. Pzena Investment Management LLC grew its holdings in USANA Health Sciences by 9.4% in the second quarter. Pzena Investment Management LLC now owns 1,198,260 shares of the company’s stock worth $36,583,000 after purchasing an additional 103,074 shares during the last quarter. Finally, Hsbc Holdings PLC grew its holdings in USANA Health Sciences by 87.9% in the first quarter. Hsbc Holdings PLC now owns 14,750 shares of the company’s stock worth $403,000 after purchasing an additional 6,902 shares during the last quarter. 54.25% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on USNA shares. Zacks Research lowered shares of USANA Health Sciences from a “hold” rating to a “strong sell” rating in a report on Tuesday, October 21st. Wall Street Zen lowered shares of USANA Health Sciences from a “buy” rating to a “hold” rating in a report on Saturday, October 11th. Finally, Weiss Ratings reissued a “sell (d+)” rating on shares of USANA Health Sciences in a report on Wednesday, October 8th. Two analysts have rated the stock with a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Reduce” and a consensus target price of $36.00.

Insiders Place Their Bets

In related news, insider David Mulham Mulham sold 3,515 shares of the business’s stock in a transaction on Wednesday, July 30th. The shares were sold at an average price of $30.26, for a total transaction of $106,363.90. Following the completion of the transaction, the insider directly owned 9,260 shares in the company, valued at $280,207.60. The trade was a 27.51% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Gilbert A. Fuller sold 1,058 shares of the business’s stock in a transaction on Thursday, August 7th. The shares were sold at an average price of $29.10, for a total transaction of $30,787.80. The disclosure for this sale can be found here. Insiders own 0.63% of the company’s stock.

USANA Health Sciences Price Performance

NYSE USNA opened at $20.17 on Tuesday. The company has a market capitalization of $368.43 million, a PE ratio of 22.92, a P/E/G ratio of 1.00 and a beta of 0.61. The company has a fifty day moving average of $27.66 and a 200 day moving average of $28.92. USANA Health Sciences, Inc. has a 1 year low of $18.69 and a 1 year high of $41.83.

USANA Health Sciences (NYSE:USNA) last posted its earnings results on Thursday, October 9th. The company reported $0.56 earnings per share (EPS) for the quarter. The company had revenue of $200.22 million during the quarter. USANA Health Sciences had a net margin of 1.86% and a return on equity of 6.96%. USANA Health Sciences has set its Q3 2025 guidance at -0.150–0.150 EPS. Research analysts expect that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current year.

USANA Health Sciences Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.